News


Druley Lab receives $40,000 donation from the Eli Seth Matthews Leukemia Foundation!

The Druley Lab received an incredibly generous $40,000 donation from the Eli Seth Matthews Leukemia Foundation last week. We had the opportunity to have lunch and speak to Eli’s father, Paul Matthews. Eli’s story is powerful and the work being done in his legacy is moving. We want to thank both Paul and the the Foundation […]

Posted in Uncategorized | Leave a comment

Dr. Druley discusses pediatric cancer predisposition on Radio Rounds

Dr. Druley appears on Radio Rounds, a new podcast series out of St. Louis Children’s Hospital, to discuss recent advances in pediatric cancer predisposition. This interview will be featured on iHeart Radio, iTunes and StLouisChildrens.org/RadioRounds.   Click here to listen to the full podcast:

Posted in Uncategorized | Leave a comment

Lab member, Spencer, visits pediatric AML survivor, Brandon!

This summer, Spencer traveled to Hong Kong and had the opportunity to visit pediatric AML survivor, Brandon. It was a truly gratifying experience to see Brandon return to good health and we wish him the best as he starts school next week!

Posted in News | Leave a comment

Children With Birth Defects At Increased Risk for Cancer

The Cancer Predisposition Program at St. Louis Children’s Hospital, led by Dr. Todd Druley, has published a systematic review finding that pediatric cancer risk increases in association with birth defects. Notably, there is a strong, consistent association with CNS abnormalities and the incidence of CNS cancers. With novel high-throughput technologies, we may be able to find the […]

Posted in News | Leave a comment

Dr. Druley discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA.

Todd E. Druley, MD, from the Washington University School of Medicine in St. Louis, St. Louis, MO, discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA. He explains that minimal residual disease (MRD) is the assessment for residual leukemia after a patient […]

Posted in News, Research | Leave a comment